Study to Assess the Safety and Pharmacokinetics of TPOXX ® When Administered Orally for 28 Days

Condition:   Smallpox Interventions:   Biological: JYNNEOS + TPOXX;   Biological: JYNNEOS + TPOXX PLACEBO Sponsors:   SIGA Technologies;   Biomedical Advanced Research and Development Authority Not yet recruiting

Source: ClinicalTrials.gov - July 12, 2021 Category: Research Source Type: clinical trials